PRO-REHAB - The development and pilot trial of two programmes of rehabilitation for cancer patients

INTERVENTION: The two intervention arms of this three‐arm randomised control trial are home‐based rehabilitation and group‐based rehabilitation programmes. The home‐based programme is an individualised holistic rehabilitaion programme, developed jointly by the participant and a personal allied health professional and delivered over 10 weeks. Particpants can choose from a wide range of areas, activities and topics that they would like to improve or change in their lives. Participants who would like to improve activity will recieive an individualised exercise programme, developed by specialist exercise physiologists. The programme will be supported by a workbook with a goal diary and CD‐based relaxation. The group‐based programme is an holistic rehabilitaion prgramme, developed jointly by the group (maximum 10 people) and a multi‐disciplinary team of allied health professionals and delivered over 10 weeks. Participants can choose from a wide range of areas, activities and topics that they would like to improve or change in their lives. Participants who would like to improve activity will recieive an individualised exercise programme, developed by specialist exercise physiologists. The programme will be supported by a workbook with a goal diary and CD‐based relaxation. CONDITION: Rehabilitation for cancer patients following the end of their treatment ; Cancer PRIMARY OUTCOME: 1. Identification and recruitment of participants, and recruitment strategies; 2. Sample size calculations for a future multi‐centre trial SECONDARY OUTCOME: 1. European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire‐EORTC QLQ‐C30 (version 3); 2. Generalised Anxiety Disorder Assessment (GAD‐7); 3. Euroqol quality of life questionnaire (5 item) ‐ EQ5D‐5L; 4. Patient Health Questionnaire (PHQ‐9); 5. The Warwick‐Edinburgh Mental Well‐being Scale (WEMWBS); 6. The Distress Thermometer ; 7. Incremental Shuttle Walk Test (ISWT) score; 8. Joint British Societies recommendations on the prevention of Cardiovascular Disease (JBS3) score; 9. Malnutrition Universal Screening Tools score (MUST) INCLUSION CRITERIA: Patients: 1. With cancer (breast, colorectal, head and neck, lung and prostate) of any stage, will be invited to participate along with their carers 2. Who have completed the initial phase of intensive intervention (surgery, chemotherapy and/or radiotherapy) 3. Are able to read written and comprehend spoken English 4. Are aged 18 years and over 5. Are able and willing to give informed consent; Target Gender: Male & Female ; Lower Age Limit 18 no age limit or unit specified